Preclinical Risk Evaluation of Normal Tissue Injury With Novel Radiosensitizers.
Dragojevic S, Ji J, Singh PK, Connors MA, Mutter RW, Lester SC, Talele SM, Zhang W, Carlson BL, Remmes NB, Park SS, Elmquist WF, Krishnan S, Tryggestad EJ, Sarkaria JN.
Dragojevic S, et al.
Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):e54-e62. doi: 10.1016/j.ijrobp.2021.08.003. Epub 2021 Aug 14.
Int J Radiat Oncol Biol Phys. 2021.
PMID: 34400266
Free PMC article.
Review.
However, patients with homozygous inactivating mutations of ataxia telangiectasia mutated or mice with homozygous defects in DNA-dependent protein kinase (severe combined immunodeficiency) have profoundly enhanced acute normal tissue radiation reactions. ...In this review, …
However, patients with homozygous inactivating mutations of ataxia telangiectasia mutated or mice with homozygous defects in DNA-depe …